Collection

Biomaterials and Tissue engineering

Aims

This special issue provides recent advances and emerging developments for the science and technologies in biotechnology, bioengineering, tissue engineering and biomaterials.

Our aim is to encourage scientists and engineers to publish their collaborative experimental and theoretical results in biology, medicine, chemical engineering, and other disciplines.

Scope

Scope of this special issue include a wide range of bioengineering and tissue engineering, not limited to the following areas of research fields:

- Biomaterials for cell-based therapies and for drug delivery

- Technologies for the applications of biomaterials into tissue engineering constructs with nanofibrous, microfibrous and macroporous three-dimensional architectures

- The use of biomaterials in a wide range of tissue engineered strategies such as bone, cartilage, tendons and ligaments, skin, cardiac muscle, vascular tissues and neural tissues,

- Issues in further advancing existing therapies with new aspects of tissue engineering strategies (e.g. biomechanical and electrical aspects of tissue engineering)

Editors

  • Chang-Soo Lee

    I have been working for the Chemical Engineering Department at Chungnam National University. I study how a detailed understanding of microfluidic phenomena improves engineering ability to integrate chemical and biological reactions in defined systems and ultimately human health risks. The application of this research is important in efforts to realize a user-friend screening system, find useful compounds, and emulate a biological system for probing the role of a biological phenomenon.

  • Soonjo Kwon

    Soonjo Kwon is Professor in Biological Engineering at the Inha University, Korea. He is also Non-executive Director of Samsung Biologics. He was a Professor in Biological Engineering at the Utah State University and in Chemical and Biomedical Engineering at the Florida State University. He got Ph.D. in Chemical Engineering and Materials Science at the University of California, Irvine in 2000. He was Postdoctoral Fellow in Bioengineering at the University of California, San Diego from 2000 to 2002. His current research activities focus on Cell-based Therapies and Enhanced Drug Delivery.

Articles (21 in this collection)